Patient´s awareness of a direct adverse drug reaction reporting system: an exploratory survey conducted at the Medical Center - University of Freiburg.

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00007917

Enrollment

150

Registered

2015-06-24

Start date

2015-06-24

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Report of adverse drug reactions by patients.

Interventions

Group 1: Patients from three different clinical departments at the Medical Center - University of Freiburg (Clinic of Dermatology and Venereology, Clinic of Rheumatology and Clinical Immunology and De

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Patients that are treated in one of the three clinical departments.

Exclusion criteria

Exclusion criteria: Under age.

Design outcomes

Primary

Measure	Time frame
it should be investigated whether patients are aware that they can report adverse drug reactions directly to the German competent authorities (Federal Institute for Drugs and Medical Devices (BfArM) and the Paul Ehrlich Institute (PEI)).	—

Secondary

Measure	Time frame
Additionally it should be investigated whether adverse drug reaction reporting rates differ among three clinical departments at the Medical Center – University of Freiburg.	—

Countries

Germany

Contacts

Public ContactAndrea Luizari Buss

Universitätsklinikum FreiburgStudienzentrum

andrea.luizari@hotmail.com+ 49 (0) 761 270 77763 / 67141

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026